Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06050265 · ClinicalTrials.gov registry record · NA
Glucose Evaluation Through Continuous Glucose Monitors in Polycystic Ovary Syndrome
A NA study of Insulin Resistance and Dysglycemia, sponsored by University of California, San Francisco.
- Active
- Registry status
- NA
- Development phase
- 56
- Enrollment target
- 1
- Study location
NCT06050265 is a NA study of Insulin Resistance and Dysglycemia that is active but no longer recruiting, run by University of California, San Francisco. The registered enrollment target is 56 participants, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06050265, a NA study of Insulin Resistance and Dysglycemia, is active but no longer recruiting, sponsored by University of California, San Francisco.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 56 participants
- Enrollment target
- 1
- Study location
Study Summary
PCOS is the most common endocrine disorder of reproductive aged women. In addition to menstrual and endocrine abnormalities, PCOS is characterized by insulin resistance and glycemic dysregulation. The pattern of glycemic abnormalities among patients with PCOS may be different than the general population, as evidenced by invasive, time consuming, and costly procedures such as the euglycemic clamp or oral glucose tolerance test. Continuous glucose monitoring (CGM) offers an opportunity to evaluate glycemic status in real world conditions. Furthermore, use of a CGM has been found to improve glycemic status among those with prediabetes and diabetes, but little is known about utility among patients with PCOS. The investigators thus seek to 1) characterize glycemic status using CGM among patients with PCOS and 2) assess the impact of CGM use on metabolic and reproductive health in patients with PCOS.
Conditions Studied
Interventions
- DEVICE DEXCOM Continuous Glucose Monitor (CGM)
Study Locations (1)
California
- UCSF Center for Reproductive Health - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2023-11-29 |
| Est. Completion | 2026-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06050265
The ClinicalTrials.gov registry entry for NCT06050265 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (77% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Insulin Resistance appearing as the primary indexed condition, and to 1 intervention - of which DEXCOM Continuous Glucose Monitor (CGM) is the first listed.
NCT06050265 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06050265 about?
NCT06050265 is a clinical study titled "Glucose Evaluation Through Continuous Glucose Monitors in Polycystic Ovary Syndrome". PCOS is the most common endocrine disorder of reproductive aged women. In addition to menstrual and endocrine abnormalities, PCOS is characterized by insulin resistance and glycemic dysregulation. The pattern of glycemic abnormalities among patients with PCOS may be different than the general popula...
What is the current status of trial NCT06050265?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 56 participants. The study started on 2023-11-29. Estimated completion is 2026-12-01.
What conditions does trial NCT06050265 study?
This clinical trial studies the following conditions: Insulin Resistance, Dysglycemia, PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries.
What interventions are being tested in trial NCT06050265?
The interventions under investigation include: DEXCOM Continuous Glucose Monitor (CGM) (DEVICE).
Who is sponsoring clinical trial NCT06050265?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06050265 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insulin Resistance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling
RECRUITING · NA
-
Small Extracellular Vesicles and Insulin Action
RECRUITING · NA
-
Exercise Effects on Adipose Tissue Structure and Function
RECRUITING · NA
-
New Mechanisms of Obesity
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.